Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laith J Abu-Raddad

Showing results (211-220 of 318) with videos related to

Pageof 32
Sort By:
Journal of Medical Microbiology|May 13, 2025
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severityFatma H Ali, Giusy Gentilcore, Hadeel T Al-Jighefee, et al.
Journal of Infection and Public Health|November 16, 2024
Seroprevalence and detection of Human herpesvirus-8 (HHV-8) among healthy blood donors residing in QatarHadeel T Zedan, Alaa Elkhider, Asalet Hicazi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 10, 2021
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After VaccinationAdeel A Butt, Hanaa Nafady-Hego, Hiam Chemaitelly, et al.
Eclinicalmedicine|January 7, 2025
Syphilis infection prevalence in the Middle East and North Africa: a systematic review and meta-analysisMariam El-Jamal, Beyhan Annan, Alaa Al Tawil, et al.
JAMA Network Open|June 30, 2023
Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 VaccinationHadeel T Zedan, Maria K Smatti, Swapna Thomas, et al.
Acta Tropica|March 27, 2026
Toxoplasma gondii IgG Seroprevalence in Qatar and the Impact of Assay Variability on Epidemiological EstimatesNadin Younes, Reem Al-Ansari, Rahma Ibrahim, et al.
Journal of Medical Virology|April 29, 2024
Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigensSwapna Thomas, Maria K Smatti, Haya Alsulaiti, et al.
Journal of Travel Medicine|November 7, 2022
Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infectionHaissam Abou-Saleh, Bushra Y Abo-Halawa, Salma Younes, et al.
Microorganisms|January 28, 2021
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 IndividualsSalma Younes, Hadeel Al-Jighefee, Farah Shurrab, et al.
Lancet (London, England)|February 24, 2022
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionDaniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, et al.
Pageof 32

Showing results (211-220 of 318) with videos related to

Sort By:
Pageof 32
Journal of Medical Microbiology|May 13, 2025
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severityFatma H Ali, Giusy Gentilcore, Hadeel T Al-Jighefee, et al.
Journal of Infection and Public Health|November 16, 2024
Seroprevalence and detection of Human herpesvirus-8 (HHV-8) among healthy blood donors residing in QatarHadeel T Zedan, Alaa Elkhider, Asalet Hicazi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 10, 2021
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After VaccinationAdeel A Butt, Hanaa Nafady-Hego, Hiam Chemaitelly, et al.
Eclinicalmedicine|January 7, 2025
Syphilis infection prevalence in the Middle East and North Africa: a systematic review and meta-analysisMariam El-Jamal, Beyhan Annan, Alaa Al Tawil, et al.
JAMA Network Open|June 30, 2023
Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 VaccinationHadeel T Zedan, Maria K Smatti, Swapna Thomas, et al.
Acta Tropica|March 27, 2026
Toxoplasma gondii IgG Seroprevalence in Qatar and the Impact of Assay Variability on Epidemiological EstimatesNadin Younes, Reem Al-Ansari, Rahma Ibrahim, et al.
Journal of Medical Virology|April 29, 2024
Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigensSwapna Thomas, Maria K Smatti, Haya Alsulaiti, et al.
Journal of Travel Medicine|November 7, 2022
Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infectionHaissam Abou-Saleh, Bushra Y Abo-Halawa, Salma Younes, et al.
Microorganisms|January 28, 2021
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 IndividualsSalma Younes, Hadeel Al-Jighefee, Farah Shurrab, et al.
Lancet (London, England)|February 24, 2022
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionDaniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, et al.
Pageof 32